XINGANJIANG
873167
INNOVATIVE DATA
835305
CHENGUANG MEDICAL
430300
4
Hangzhou Gaoxin Materials Technology
300478
5
Beijing Philisense Technology
300287
(FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | |
---|---|---|---|---|---|---|---|---|---|---|
Total revenue | 2.96%11.3B | 4.09%2.6B | 5.39%3.07B | 0.94%2.68B | 1.41%2.96B | 14.72%10.98B | 19.40%2.49B | 8.53%2.91B | 24.72%2.65B | 9.33%2.92B |
Operating revenue | 2.88%11.17B | 4.24%2.56B | 5.34%3.04B | 0.72%2.65B | 1.25%2.93B | 14.50%10.85B | 19.14%2.45B | 8.22%2.88B | 24.68%2.63B | 9.10%2.89B |
Cost of revenue | 3.52%9.41B | 2.52%2.24B | 5.35%2.52B | 1.45%2.24B | 4.55%2.42B | 11.68%9.09B | 18.44%2.18B | 10.48%2.39B | 19.24%2.21B | 1.23%2.31B |
Gross profit | 0.27%1.89B | 15.21%356M | 5.57%550M | -1.56%441M | -10.54%543M | 32.10%1.89B | 26.64%309M | 0.39%521M | 61.15%448M | 57.25%607M |
Operating expense | -8.24%690M | -1.05%188M | -13.64%171M | -8.47%162M | -9.63%169M | -2.21%752M | -1.55%190M | -0.50%198M | -3.28%177M | -3.61%187M |
Selling and administrative expenses | -10.97%568M | 1.96%156M | -17.75%139M | -13.07%133M | -14.11%140M | 7.41%638M | 5.52%153M | 7.64%169M | 8.51%153M | 7.95%163M |
-General and administrative expense | -10.97%568M | 1.96%156M | -17.75%139M | -13.07%133M | -14.11%140M | 7.41%638M | 5.52%153M | 7.64%169M | 8.51%153M | 7.95%163M |
Depreciation amortization depletion | ---- | ---- | ---- | ---- | ---- | -97.94%2M | ---- | ---- | ---- | ---- |
-Depreciation and amortization | ---- | ---- | ---- | ---- | ---- | -97.94%2M | ---- | ---- | ---- | ---- |
Other operating expenses | 8.93%122M | -8.57%32M | 10.34%32M | 20.83%29M | 20.83%29M | 43.59%112M | 40.00%35M | 61.11%29M | 33.33%24M | 41.18%24M |
Operating profit | 5.91%1.2B | 41.18%168M | 17.34%379M | 2.95%279M | -10.95%374M | 72.19%1.13B | 133.33%119M | 0.94%323M | 185.26%271M | 118.75%420M |
Net non-operating interest income expense | -23.67%129M | -35.56%29M | -32.61%31M | -22.50%31M | 0.00%38M | 101.19%169M | 36.36%45M | 84.00%46M | 185.71%40M | 216.67%38M |
Non-operating interest income | -23.67%129M | -35.56%29M | -32.61%31M | -22.50%31M | 0.00%38M | 101.19%169M | 36.36%45M | 84.00%46M | 185.71%40M | 216.67%38M |
Other net income (expense) | 102.63%2M | -3.85%-27M | 750.00%26M | 80.00%-5M | 138.10%8M | -38.18%-76M | -550.00%-26M | 78.95%-4M | -516.67%-25M | 44.74%-21M |
Gain on sale of security | 185.11%40M | 33.33%-10M | 950.00%34M | 172.73%8M | 147.06%8M | -104.35%-47M | -287.50%-15M | 73.33%-4M | -155.00%-11M | 52.78%-17M |
Earnings from equity interest | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
Special income (charges) | -34.48%-39M | -41.67%-17M | ---8M | 7.14%-13M | 66.67%-1M | 9.38%-29M | 0.00%-12M | --0 | 0.00%-14M | -50.00%-3M |
-Less:Restructuring and merger&acquisition | ---- | ---- | ---- | ---- | ---- | --0 | ---- | ---- | ---- | ---- |
-Gain on sale of business | -34.48%-39M | -41.67%-17M | ---8M | 7.14%-13M | 66.67%-1M | 9.38%-29M | 0.00%-12M | --0 | 0.00%-14M | -50.00%-3M |
Other non- operating income (expenses) | --1M | ---- | ---- | ---- | 200.00%1M | ---- | ---- | ---- | ---- | ---1M |
Income before tax | 8.56%1.33B | 23.19%170M | 19.45%436M | 6.64%305M | -3.89%420M | 78.46%1.23B | 72.50%138M | 11.96%365M | 148.70%286M | 163.25%437M |
Income tax | 8.21%356M | 42.42%47M | 19.00%119M | 8.45%77M | -9.60%113M | 58.94%329M | 37.50%33M | 3.09%100M | 129.03%71M | 127.27%125M |
Earnings from equity interest net of tax | 25.00%5M | 50.00%3M | 0.00%2M | --0 | --0 | 300.00%4M | 0.00%2M | 200.00%2M | 0.00%-1M | 200.00%1M |
Net income | 8.77%980M | 17.76%126M | 19.48%319M | 6.54%228M | -1.92%307M | 88.49%901M | 84.48%107M | 17.62%267M | 157.83%214M | 184.55%313M |
Net income continuous Operations | 8.77%980M | 17.76%126M | 19.48%319M | 6.54%228M | -1.92%307M | 88.49%901M | 84.48%107M | 17.62%267M | 157.83%214M | 184.55%313M |
Minority interest income | -6.76%69M | 10.00%11M | -4.35%22M | -5.88%16M | -16.67%20M | 105.56%74M | 100.00%10M | 9.52%23M | 17M | 140.00%24M |
Net income attributable to the parent company | 10.16%911M | 18.56%115M | 21.72%297M | 7.61%212M | -0.69%287M | 87.10%827M | 83.02%97M | 18.45%244M | 137.35%197M | 189.00%289M |
Preferred stock dividends | ||||||||||
Other preferred stock dividends | ||||||||||
Net income attributable to common stockholders | 10.16%911M | 18.56%115M | 21.72%297M | 7.61%212M | -0.69%287M | 87.10%827M | 83.02%97M | 18.45%244M | 137.35%197M | 189.00%289M |
Basic earnings per share | 17.59%2.34 | 30.43%0.3 | 30.51%0.77 | 17.02%0.55 | 4.35%0.72 | 89.52%1.99 | 76.92%0.23 | 20.41%0.59 | 135.00%0.47 | 200.00%0.69 |
Diluted earnings per share | 18.27%2.33 | 30.43%0.3 | 32.76%0.77 | 17.02%0.55 | 4.41%0.71 | 89.42%1.97 | 76.92%0.23 | 18.37%0.58 | 135.00%0.47 | 195.65%0.68 |
Dividend per share | 23.08%0.64 | 23.08%0.16 | 23.08%0.16 | 23.08%0.16 | 23.08%0.16 | 8.33%0.52 | 8.33%0.13 | 8.33%0.13 | 8.33%0.13 | 8.33%0.13 |
Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
Audit Opinions | -- | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |